What is McKesson Corporation's primary business according to this filing?

According to this 10-K filing for the fiscal year ending March 30, 1996, McKesson Corporation is primarily engaged in the distribution of pharmaceuticals and health care products.

What fiscal period does this 10-K report cover?

This 10-K annual report covers the fiscal period ending on March 30, 1996.

What are the key areas an investor should focus on in this filing?

Investors should focus on McKesson's financial performance, its market share and competitive position within the healthcare distribution sector, any significant strategic initiatives or acquisitions, and the company's ability to navigate the regulatory and operational complexities of the healthcare industry.

What was the economic or industry context for McKesson in 1996?

In 1996, the healthcare industry was undergoing significant changes, with increasing focus on cost containment, the growth of managed care, and advancements in healthcare technology. McKesson's role as a distributor placed it at a critical juncture in this evolving landscape, influencing its supply chain, product offerings, and market strategies.

MCK 10-K FY1996 Annual Report — Revenue, Net Income, EPS

Summary

McKesson Corporation's 1996 10-K filing covers the fiscal year ending March 30, 1996. As a major distributor of pharmaceuticals and health care products, McKesson's performance is closely tied to the healthcare industry's dynamics. This report provides a snapshot of the company's financial position and operational highlights during a period of significant growth and evolution in healthcare services and technology. Investors can gain insights into McKesson's strategic direction, its market share in key segments, and its approach to managing a complex supply chain. The filing would typically detail revenue streams, product lines, any significant acquisitions or divestitures, and the regulatory environment impacting its operations. Understanding these elements is crucial for assessing the company's stability, growth potential, and overall investment attractiveness in the mid-1990s healthcare landscape.

Key Highlights

1McKesson Corporation is a significant player in the distribution of pharmaceuticals and health care products.
2The filing covers the fiscal year ending March 30, 1996.
3The company operates within the dynamic and evolving healthcare industry.
4Key aspects likely covered include financial performance, market position, and operational strategies.
5The report provides insights into McKesson's supply chain management and distribution capabilities.
6Investors can assess the company's growth trajectory and competitive standing in the healthcare sector.

MCKESSON CORP Annual Report, Year Ended Mar 31, 1996

Summary

Key Highlights

Frequently Asked Questions